在乳腺癌中SUMOylation和其他翻译后修改之间的交叉关系
Bajin Wei1, Fan Yang2, Luyang Yu3,4
1The Department of Breast Surgery, Key Laboratory of Organ Transplantation, Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cellular & molecular biology letters
|August 10, 2024
概括
包括SUMOylation在内的蛋白质翻译后修饰 (PTM) 是乳腺癌的关键. 本综述详细介绍了SUMOylation如何与其他PTM相互作用以推动癌症进展,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌是全世界妇女死亡的主要原因.
- 蛋白质翻译后修饰 (PTMs) 调节乳腺癌的发展.
- 小型泛素类修饰剂 (SUMOylation) 是乳腺癌中关键的PTM.
研究的目的:
- 审查乳腺癌中SUMOylation和其他PTM之间交叉的新型和现有机制.
- 阐明这些相互作用背后的分子机制.
- 在乳腺癌治疗中探索SUMOylation-PTM交叉的潜在治疗应用.
主要方法:
- 关于乳腺癌中SUMOylation和PTM交叉的最近研究的文献综述.
- 对分子机制的分析,包括反控制和其他PTM的调制.
- 识别蛋白质和特定部位的相互作用.
主要成果:
- 在乳腺癌中,SUMOylation 与酸化,无化,乙化和甲基化相互作用.
- 这些相互作用是特定于蛋白质和位点的,影响瘤发生和进展.
- 机制涉及负责人,形状和场地占用情况的改变.
结论:
- 在乳腺癌中,SUMOylation与其他PTM之间的交叉作用起着重要作用.
- 了解这些相互作用提供了对乳腺癌病理学的见解.
- 准SUMOylation-PTM交叉可能会导致新的乳腺癌疗法.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Expression at Multiple Steps
879
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
879
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


